According to the company, the new application will help the researchers in improving accuracy while assessing drug safety and effectiveness, testing for drug interactions and developing new drugs.
HP’s methodology also can decrease expensive labware and biological fluid waste associated with complex, conventional testing methods, reducing research costs.
HP president of IT Strategies Mark Hanley said inkjet technology brings efficiencies to the drug discovery process that it brought to printing, allowing for on-demand, small-volume, high-precision production at costs significantly lower than existing analog processes.